Customer Story
From complexity to success: GOLLMANN wins Forschungszulage with innoscripta
End-to-end funding process management
Centralized R&D project documentation
Industry
Machinery & Equipment Manufacturing, Industrial Automation
Company Size
Large Enterprise
Location
Halle, Germany
“They guided us extremely well, quickly connected us with the right meetings and questions to reach our goal, and enabled us to secure the research allowance in a very short time.”
Meet GOLLMANN
Founded in 2006 and headquartered in Halle, GOLLMANN designs and manufactures fully automated solutions for pharmacies and hospitals, and its workforce comprises more than 400 employees.
The company designs customised, long-term systems for pharmacies and hospitals that combine exceptional reliability, usability, and precision engineering. With over 80% vertical integration at the production site, they operate with a diverse team of specialists from more than 30 countries. As an owner-managed company, GOLLMANN values independence and customer-oriented solutions. That is why GOLLMANN has its customer base in over 25 countries. They integrate global standards, ensuring innovation and reliability in every solution they provide.
The Challenge
In spite of being a highly innovative company with excellent R&D work, GOLLMANN had no prior knowledge of the research allowance programme. The research allowance was perceived as an opportunity that was strenuous to approach independently without expert guidance.
Key difficulties GOLLMANN faced in the process include:
- Assessing the eligibility of R&D projects for a successful research allowance claim.
- Extensive documentation process with detailed technical justifications.
- The absence of structured preparations and expertise to proceed with the applications.
The Solution
innoscripta provided holistic support to GOLLMANN in the whole process, from the initial stage of assessing the eligibility of the R&D project for the research allowance to placing a successful claim.
Guided understanding: innoscripta proactively introduced each concept of the research allowance programme by clearly demonstrating the benefits and feasibility of applying.
Complete project visibility: innoscripta's software platform strengthened the entire process by centralising project documentation, ensuring data completeness, and offering seamless tracking of both project progress and application submissions.
Structured process management: “Beyond the software, the real strength at innoscripta and something that was also pointed out to us was definitely the management of the process.”
Along with the innoscripta software, the team from innoscripta ensured systematic process management that enhanced both, speed and accuracy. The innoscripta team effectively handled:
- Setting clear timelines and supporting GOLLMANN in managing project details.
- Defining the right questions and milestones to guide internal work.
The Impact
innoscripta was able to create long-term value for GOLLMANN and empowered them to successfully navigate through the research allowance program.
100% funding success: innoscripta's expertise combined with the dedicated software enabled GOLLMANN to successfully acquire the research allowance for all the projects they applied for.
Swift results: Through effective coordination, precise project documentation, and continued support, innoscripta accelerated the application process and generated remarkable positive outcomes within a short timeframe.
Conclusion
“We would recommend the team at innoscripta at any time.”
Daniel Gollmann expresses full satisfaction with the support innoscripta provided in the process and highlights it by vouching for innoscripta to other companies aiming to seek financial support under the Forschungszulage.
